Proteomics

Study reveals that ALS and Parkinson disease distinguishing protein biomarkers differ

Published in Drug Week, January 27th, 2006

Power3 Medical Products, Inc. (PWRM.PK) revealed for the first time that three blood serum protein biomarkers useful in distinguishing patients with ALS (Lou Gehrig disease) and Parkinson disease are actually different forms of the same protein, where the disease specific difference involves an important regulatory mechanism, the attachment of a tag to the protein.

"This is a new and exciting finding, that three biochemically distinct forms of the same protein have been found to differ in the blood serum from patients with Parkinson disease and ALS," said Dr. Ira L. Goldknopf, an early pioneer in the science of proteomics and chief scientific officer of Power3. "This is...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2006-01-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry